145 related articles for article (PubMed ID: 9531717)
21. In vitro short-time killing activity of povidone-iodine (Isodine Gargle) in the presence of oral organic matter.
Yoneyama A; Shimizu M; Tabata M; Yashiro J; Takata T; Hikida M
Dermatology; 2006; 212 Suppl 1():103-8. PubMed ID: 16490985
[TBL] [Abstract][Full Text] [Related]
22. In-vitro evaluation of povidone-iodine and chlorhexidine against methicillin-resistant Staphylococcus aureus.
McLure AR; Gordon J
J Hosp Infect; 1992 Aug; 21(4):291-9. PubMed ID: 1355784
[TBL] [Abstract][Full Text] [Related]
23. In-vitro activities of five plant essential oils against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
Nelson RR
J Antimicrob Chemother; 1997 Aug; 40(2):305-6. PubMed ID: 9302003
[No Abstract] [Full Text] [Related]
24. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the antibacterial activity of an ozonated oil with chlorhexidine digluconate and povidone-iodine. A disk diffusion test.
Montevecchi M; Dorigo A; Cricca M; Checchi L
New Microbiol; 2013 Jul; 36(3):289-302. PubMed ID: 23912871
[TBL] [Abstract][Full Text] [Related]
26. Suprathel-antiseptic matrix: in vitro model for local antiseptic treatment?
Ryssel H; Andreas Radu C; Germann G; Kloeters O; Riedel K; Otte M; Kremer T
Adv Skin Wound Care; 2011 Feb; 24(2):64-7. PubMed ID: 21242734
[TBL] [Abstract][Full Text] [Related]
27. An innovative topical drug formulation for wound healing and infection treatment: in vitro and in vivo investigations of a povidone-iodine liposome hydrogel.
Reimer K; Vogt PM; Broegmann B; Hauser J; Rossbach O; Kramer A; Rudolph P; Bosse B; Schreier H; Fleischer W
Dermatology; 2000; 201(3):235-41. PubMed ID: 11096195
[TBL] [Abstract][Full Text] [Related]
28. Bactericidal activity of antiseptics against methicillin-resistant Staphylococcus aureus.
Haley CE; Marling-Cason M; Smith JW; Luby JP; Mackowiak PA
J Clin Microbiol; 1985 Jun; 21(6):991-2. PubMed ID: 4008627
[TBL] [Abstract][Full Text] [Related]
29. An in-vitro evaluation of the activity of povidone-iodine against nosocomial bacterial strains.
Traoré O; Fayard SF; Laveran H
J Hosp Infect; 1996 Nov; 34(3):217-22. PubMed ID: 8923277
[TBL] [Abstract][Full Text] [Related]
30. In vitro bactericidal activity of 0.6% povidone-iodine eye drops formulation.
Musumeci R; Bandello F; Martinelli M; Calaresu E; Cocuzza CE
Eur J Ophthalmol; 2019 Nov; 29(6):673-677. PubMed ID: 30295039
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial activity of clinically used antiseptics and wound irrigating agents in combination with wound dressings.
Hirsch T; Limoochi-Deli S; Lahmer A; Jacobsen F; Goertz O; Steinau HU; Seipp HM; Steinstraesser L
Plast Reconstr Surg; 2011 Apr; 127(4):1539-1545. PubMed ID: 21187812
[TBL] [Abstract][Full Text] [Related]
32. Effects of Diluents, Saliva and Other Organics on the Microbicidal Activity of Cetylpyridinium Chloride and Povidone-iodine.
Urakawa R; Inubushi J; Tobata H; Eguchi T
Biocontrol Sci; 2020; 25(2):45-53. PubMed ID: 32507790
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of povidone-iodine as a disinfectant solution for contact lenses: antimicrobial activity and cytotoxicity for corneal epithelial cells.
Yanai R; Yamada N; Ueda K; Tajiri M; Matsumoto T; Kido K; Nakamura S; Saito F; Nishida T
Cont Lens Anterior Eye; 2006 May; 29(2):85-91. PubMed ID: 16621674
[TBL] [Abstract][Full Text] [Related]
34. Bactericidal activity of 3 cutaneous/mucosal antiseptic solutions in the presence of interfering substances: Improvement of the NF EN 13727 European Standard?
Salvatico S; Feuillolay C; Mas Y; Verrière F; Roques C
Med Mal Infect; 2015 Mar; 45(3):89-94. PubMed ID: 25779009
[TBL] [Abstract][Full Text] [Related]
35. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
Jones ME
Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
[TBL] [Abstract][Full Text] [Related]
36. Effects of Betaisodona on parameters of host defense.
König B; Reimer K; Fleischer W; König W
Dermatology; 1997; 195 Suppl 2():42-8. PubMed ID: 9403254
[TBL] [Abstract][Full Text] [Related]
37. Mixture of sugar and povidone-iodine stimulates healing of MRSA-infected skin ulcers on db/db mice.
Shi CM; Nakao H; Yamazaki M; Tsuboi R; Ogawa H
Arch Dermatol Res; 2007 Nov; 299(9):449-56. PubMed ID: 17680256
[TBL] [Abstract][Full Text] [Related]
38. An evaluation of the suitability of the European suspension test to reflect in vitro activity of antiseptics against clinically significant organisms.
Payne DN; Babb JR; Bradley CR
Lett Appl Microbiol; 1999 Jan; 28(1):7-12. PubMed ID: 10030024
[TBL] [Abstract][Full Text] [Related]
39. In vitro action of combinations of selected antimicrobial agents and adult bovine articular cartilage (sesamoid bone).
Müller G; Kramer A
Chem Biol Interact; 2003 Jun; 145(3):331-6. PubMed ID: 12732459
[TBL] [Abstract][Full Text] [Related]
40. [Activity of frequently used disinfectants and antiseptics against nosocomial bacterial types].
Ozkurt Z; Altoparlak U; Erol S; Celebi S
Mikrobiyol Bul; 2003; 37(2-3):157-62. PubMed ID: 14593898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
